EditorialKommentar
The combination of ALBI and AFP response: A small step forward in HCC
Liver International · 2023
DOI: 10.1111/liv.15494 ↗Kurz gefasst
Editorial in der Zeitschrift Liver International, 2023. Verfasst von Landon L Chan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Princess Margaret Hospital, Hong Kong, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Carcinoma, HepatocellularLiver NeoplasmsHumansalpha-FetoproteinsBilirubinSerum AlbuminPrognosisRetrospective Studies
Substanzen
alpha-FetoproteinsBilirubinSerum Albumin
Autor:innen und Institutionen
- Department of Oncology, Princess Margaret Hospital, Hong Kong, China.
- Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, China.
- State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, China.
ORCID-Profile: Landon L Chan
Zitieren
APA
Chan, L. L., & Chan, S. L. (2023). The combination of ALBI and AFP response: A small step forward in HCC. Liver International. https://doi.org/10.1111/liv.15494
Vancouver
Chan LL, Chan SL. The combination of ALBI and AFP response: A small step forward in HCC. Liver International. 2023. doi:10.1111/liv.15494
BibTeX
@article{Chan2023,
author = {Chan, Landon L and Chan, Stephen L},
title = {The combination of ALBI and AFP response: A small step forward in HCC},
journal = {Liver International},
year = {2023},
doi = {10.1111/liv.15494}
}
EUVIMED